• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review

    2022-06-11 07:23:08DeepakToorJonathanLoreeZuHuaGaoGangWangChenZhou
    World Journal of Gastroenterology 2022年19期

    Deepak Toor, Jonathan M Loree, Zu-Hua Gao, Gang Wang, Chen Zhou

    Abstract Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are rare mixed tumors containing both neuroendocrine (NE) and non-NE components. Each component must occupy at least 30 % of the tumor volume by definition. Recent molecular evidence suggests MiNENs are clonal neoplasms and potentially harbor targetable mutations similar to conventional carcinomas. There have been multiple changes in the nomenclature and classification of MiNENs which has created some confusion among pathologists on how to integrate the contributions of each component in a MiNEN, an issue which in turn has resulted in confusion in communication with front-line treating oncologists. This mini review summarizes our current understanding of MiNENs and outline diagnosis,prognosis, and management of these neoplasms. The authors emphasize the importance of treating the most aggressive component of the tumor regardless of its percentage volume.

    Key Words: Mixed neuroendocrine non-neuroendocrine neoplasms; Mixed adenoneuorendocrine carcinoma; Mixed neuroendocrine neoplasms; Neuroendocrine;Non-neuroendocrine

    INTRODUCTION

    Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are tumors containing two or more histologically distinct components with one component showing neuroendocrine (NE) differentiation[1 ]. The non-NE component consists of an adenocarcinoma in over 90 % of cases, but it can consist of any other epithelial neoplasm, including squamous cell carcinoma or hepatocellular carcinoma[1 ,2 ]. By definition each component must individually comprise > 30 % of the total tumor volume in order for the tumor to qualify as a MiNEN[3 ].

    MiNENs are a specific subtype of mixed NE neoplasms (Figure 1 )[4 ]. Traditionally, mixed NE neoplasms include composite tumor, collision tumors, amphicrine tumors and non-NE neoplasms with focal neuroendocrine differentiation (NNE-NEDs). Strictly speaking, in MiNENs the distinct NE and non-NE components are intimately intermingled and both are derived from a common single precursor cell, morphologically expressing usually as composite tumors. Collision tumors consist of two independent primary neoplasms which have grown into the same space by chance. Each neoplasm is derived from a separate precursor cell which has independently undergone its own molecular evolution[5 ]. Amphicrine neoplasms consist of a single cell type in which each cell displays both NE and non-NE phenotypes simultaneously. For example, electron microscopy may demonstrate both mucous vacuoles and neurosecretory granules in the same cell. These tumors are extremely rare, with approximately only 4 reported in the stomach[6 ] but are slightly more common in the pancreas. Despite that collision tumors might not come from a common single precursor cell; they have still been referred to as MiNENs by authors based on the traditional practice.

    NNE-NEDs are non-NE neoplasms which show NE differentiation but not enough to meet the criteria to be considered MiNENs. The exact percentage threshold of NED required to be considered a MiNEN is artificial and will likely continue to evolve in the future as we learn more about these neoplasms. The current 30 % threshold was originally defined arbitrarily in 1987 to recognize and create a new diagnostic entity for truly mixed NE tumors with substantial amounts of both non-NE and NE components, and to exclude non-NE tumors with scattered NE cells of uncertain clinical significance[4 ,7 ]. Although it has served a valuable role in the establishment of MiNENs as distinct diagnostic entities,this cut-off does not have a basis in clinical or scientific evidence[1 ]. Recent studies suggest a lower threshold may be more appropriate, with even 10 % NED significantly affecting prognosis, thus raising the possibility the formally defined threshold may change in the future[8 ,9 ]. Indeed, poorly differentiated NE or even non-NE components, even when < 5 % of the tumor volume, may determine patient outcome. Regardless of what the threshold is, it is important to note neoplasms may show a spectrum of divergent NED, and that only a subset of these neoplasms should be classified as MiNENs.

    Other entities which may be confused with MiNENs include usual adenocarcinomas displaying aberrant expression of NE markers (i.e.,synaptophysin and chromogranin) but no histologically recognizable NE morphology[7 ]. These features do not qualify a neoplasm as a MiNEN, and aberrant synaptophysin expression in conventional adenocarcinomas does not affect prognosis[10 ]. Neoplasms which overgrow and entrap physiologic NE structures, for example acinar adenocarcinoma in the pancreas which can entrap normal physiologic islets of Langerhans, should also not be mistaken for MiNENs despite the pitfall of positive staining for NE markers[7 ].

    NOMENCLATURE

    Figure 1 Classification of mixed neuroendocrine neoplasms. Mixed neuroendocrine-non-neuroendocrine neoplasms are specific mixed neuroendocrine tumors, which show an intimate mixture of neuroendocrine and non-neuroendocrine cells and are both derived from a common precursor cell. MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasms.

    The individual components of MiNENs are common entities which pathologists and oncologists encounter routinely. The major challenge in understanding MiNENs is simply an issue of nomenclature.Unfortunately, the nomenclature has undergone numerous rapid and successive changes over the past 20 years. This has been complicated by substantial changes in the nomenclature for simple pure NE neoplasms themselves which have occurred over the same timeframe. The potential clinical confusion which may occur because of these rapid changes is not insignificant. An illustrative example of such potential confusion comes from appendiceal goblet cell neoplasms which have similarly undergone numerous changes in nomenclature. Two cases diagnosed as "goblet cell adenocarcinoma" and"adenocarcinoma ex goblet cell carcinoid" were misinterpreted by oncologists as NE tumors and then considered for inappropriate adjuvant chemotherapy[11 ].

    A conceptual framework for understanding MiNENs is shown in Figure 2 . In order to constitute a MiNEN a tumor must show at least two lines of differentiation, one of which is NE and the other of which is epithelial but non-NE. In the digestive system only, there is an additional stipulation that each component of the neoplasm is required to be malignant in order for it to qualify as a MiNEN[3 ]. Lowgrade NE tumors, formerly known as carcinoids, satisfy this "malignant" requirement because of their potential for metastasis, despite their usually indolent behavior[1 ,3 ]. However indolent non-NE epithelial tumors, such as adenomas or papillomas, do not metastasize and so would not constitute MiNENs in the digestive system[3 ]. For example, mixed adenomas well-differentiated NE tumors, or"MANETs", consisting of a composite tubular adenoma-carcinoid tumor, are no longer considered MiNENs with these updated criteria[12 ]. Similarly, in-situ lesions such as intraductal papillary mucinous neoplasms of the pancreas were formerly included as potential non-NE components of digestive system MiNENs, but now have been excluded by the latest WHO classification[1 ,3 ]. The non-NE component is required to be an invasive carcinoma.

    Although perhaps daunting, becoming familiar with the host of names that has been used to refer to MiNENs in the past may help reduce confusion in clinical practice. We will attempt to briefly summarize the history of the nomenclature of MiNENs towards this end. We begin by describing the changes in nomenclature of pure NE neoplasms, before moving on to the broader category of MiNENs.

    NE neoplasms

    The nomenclature of NE neoplasms in the digestive system has undergone a series of changes in the last 20 years. After being first recognized in 1907 , NE neoplasms were designated "carcinoid tumors" and referred to as such for almost a century thereafter[8 ,13 ]. By 1994 poorly differentiated NE neoplasms were noted to have a drastically worse prognosis than their well-differentiated counterparts[8 ,14 ]. The poorly differentiated neoplasms were designated “small cell carcinomas”. The term carcinoid continued to refer to well-differentiated NE neoplasms.

    Figure 2 Conceptual framework for mixed neuroendocrine-non-neuroendocrine neoplasm of the digestive system. The tumor must include one neuroendocrine component and one non-neuroendocrine component. In the digestive system both components must have metastatic potential, excluding benign non-neuroendocrine neoplasms such as adenomas or squamous papillomas. NET: Neuroendocrine tumors; NEC: Neuroendocrine carcinomas.

    Increasing use of Ki-67 immunohistochemistry revealed a wide spectrum of proliferative rates within carcinoid tumors and small cell carcinomas. A grading system based on Ki-67 index was proposed in 2006 and formally adopted by the WHO classification in 2010 [15 ,16 ]. NE tumors with low Ki-67 indices(≤ 20 %; grades 1 or 2 ) were called neuroendocrine tumors (NETs) while tumors with high Ki-67 index (>20 %; grade 3 ) were called neuroendocrine carcinomas (NECs).

    Grade 3 tumors were recently recognized to consist of two types of tumors, although both have increased Ki-67 indices. One type of tumors shows well-differentiated morphology while another type shows poorly differentiated morphology[8 ]. Further studies have revealed tumors showing poorly differentiated morphology have half the survival of their well-differentiated counterparts[8 ]. Genetic studies further show the two tumor populations actually developviaentirely separate and independent molecular pathways[8 ,17 ]. These findings have led to any poorly differentiated tumor being referred to as a NEC, regardless of Ki-67 index. Well-differentiated tumors which are designated NETs and further graded according to their proliferation rate[3 ].

    Any NE neoplasm, either a NET or a NEC, can constitute the NE component of a MiNEN.

    Non-NE component

    Mixed NE neoplasms were first recognized in 1924 , only shortly after pure NE neoplasms themselves were first recognized[7 ,18 ]. In 1987 Lewin[4 ] formally proposed a classification system for mixed NE neoplasms in which he termed what we now call MiNENs as “composite glandular-endocrine cell carcinomas”[4 ]. His classification system distinguished these tumors from collision tumors and amphicrine tumors, as well as from usual adenocarcinomas with < 30 % NED.

    In 2000 these neoplasms were adopted into theWHO Classification of Tumors of the Digestive Systemas“mixed exocrine-endocrine carcinomas” (MEECs)[7 ,19 ]. This terminology was short-lived and changed to “mixed adenoneuroendocrine carcinoma” (MANEC) in the subsequent 2010 edition of the classification[16 ].

    It soon became apparent adenocarcinomas were not the only non-NE neoplasms observed in mixed NE tumors. Other epithelial neoplasms, such as squamous cell carcinomas and hepatocellular carcinomas, were also observed in mixed NE neoplasms[1 ,7 ]. This prompted “mixed adenoneuroendocrine carcinomas” (MANECs) to instead be viewed as “mixed neuroendocrine-non-neuroendocrine carcinomas” (Figure 3 ).

    MiNENs

    In 2016 , La Rosa et al[1 ] proposed the term "mixed neuroendocrine-non-neuroendocrine neoplasms"(MiNENs)[1 ]. The intention was to create an umbrella term for mixed NE neoplasms broad enough to encompass all the changes we have discussed so far, while also being generalizable to any mixed NE tumor occurring in any organ in the body. The latter task is difficult considering the heterogeneity in nomenclature for NE neoplasms in different sites such as the lung. It is even more difficult if one anticipates the nomenclature for pure NE neoplasms continuing to evolve in other organs such as it has in the digestive system.

    MiNENs are 'neoplasms' instead of 'carcinomas' because benign non-NE components such as adenomas or papillomas can still be a part of MiNENs in sites outside of the digestive system[1 ]. This had been the case in the digestive system as well until only recently when the latest WHO classification was published in 2019 .

    Figure 3 Evolution of the terminology of mixed neuroendocrine-non-neuroendocrine neoplasm. The terminology has been broadened to include other non-neuroendocrine epithelial components beyond adenocarcinoma as well as including indolent or benign tumors such as neuroendocrine tumors. NE:Neuroendocrine; NEC: Neuroendocrine carcinoma; NET: Neuroendocrine tumor; MEEC: Mixed exocrine-endocrine carcinoma; MANEC: Mixed adenoneuroendocrine carcinoma; MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasm.

    The current prevailing view is that MiNENs are clonal neoplasms derived from a single pluripotent stem cell[8 ]. Multiple studies have compared the mutational landscape in the NE and non-NE components and have demonstrated a common trunk of mutations shared between them, beyond which are further mutations specific to each component[20 -22 ]. Interestingly these shared mutations are very similar to the mutations found in standard pure adenocarcinomas from the same anatomic site[22 ]. For example, in the colon, MiNENs can showBRAF,KRAS, andAPCmutations in both components[22 ].The mutated genes are expressed at similar levels in both components, and expression is significantly altered in comparison to normal background tissue[20 ,21 ].

    Some authors have theorized MiNENs may begin as non-NE tumors and then at some point transdifferentiate to form an aggressive NEC component[2 ,23 -26 ]. Several reports suggestc-MycandSMARCAmutations may play a role in trans-differentiation, with one study even finding only a single additionalSMARCAmutation in the NE component of a MiNEN[23 -25 ]. Other studies have shown increased chromosomal aberrations and allelic imbalances in the NE component[26 ].

    CHALLENGES IN DIAGNOSIS

    Definitive diagnosis of a MiNEN usually follows after surgical resection. The presurgical biopsy diagnoses are roughly evenly split between 1 /3 adenocarcinoma, 1 /3 NEC, and 1 /3 suspicious for MiNEN[2 ]. The NE component tends to lie deeper in the tumor which can influence the diagnosis on biopsy depending on the depth of tumor sampled[27 ,28 ].

    Identifying the components

    Diagnosing a MiNEN is equivalent to individually diagnosing the constituent components with a few additional steps. Neither the NE nor non-NE components differ from their pure counterparts, including their immunohistochemical profiles.

    Figure 4 illustrates a typical MiNEN of colon origin. Both morphologic and immunohistochemical evidence of NED is required to diagnose a NE component in a MiNEN[3 ,7 ]. Morphologic evidence is required avoid the pitfall of focal aberrant NE marker expression on immunohistochemistry in otherwise standard non-NE tumors, a commonly recognized phenomenon with no current known clinical significance[10 ,29 ]. Common markers of NED that are used include synaptophysin, chromogranin, INSM1 , CD56 , and neuron-specific enolase. Synaptophysin is traditionally be regarded as the most sensitive and chromogranin as the most specific[30 ].

    The NE component may be either a NEC or a NET[3 ,7 ]. Ki-67 proliferative index (or equivalently mitotic rate) should be reported for all NE neoplasms, including the NE component present in MiNENs.NETs are graded as usual by Ki-67 index: Grade 1 tumors are < 3 %; grade 2 between 3 %-20 %; and grade 3 > 20 %[3 ]. Grade 3 NETs usually have a Ki-67 index less than 60 %, while the indices for NECs are higher, typically more than 50 %-60 %[8 ].

    Figure 4 Histopathology of a mixed neuroendocrine-non-neuroendocrine neoplasm of colon. A: Hematoxylin and eosin (H&E) stain of mixed neuroendocrine-non-neuroendocrine neoplasm. On the right side is a well-differentiated invasive adenocarcinoma. On the left side is a poorly differentiated neuroendocrine carcinoma (20 ×, H&E); B: The adenocarcinoma component is positive for cytokeratin 20 , but the neuroendocrine component is negative (20 ×); C:Positive synaptophysin staining in the neuroendocrine component but negative staining in the adenocarcinoma component (20 ×); D: Positive CDX2 staining in both adenocarcinoma and neuroendocrine carcinoma components (20 ×); E: Merging area of adenocarcinoma and neuroendocrine carcinoma components (20 ×); F:Positive synaptophysin staining of neuroendocrine cells in the merged area (20 ×).

    The majority of MiNENs do not contain NETs but rather contain poorly differentiated NECs. Tumor cells in NECs show nuclear crowding and pleomorphism. Nuclei are hyperchromatic with increased nuclear membrane irregularity. Single cells are common, and mitoses are obvious. Necrosis can be present, and nuclei display smearing or crush artifact. NE markers remain sensitive, however immunohistochemical markers for the primary site of origin are lost[8 ,30 ]. Aberrant expression of TTF-1 and CDX-2 is common, making these markers unreliable and a potential pitfall for mistaking the site of origin[8 ]. The average Ki-67 proliferative index of NECs in MiNENs is 70 %[30 ].

    Morphologically NECs can show either small or large cell patterns. Small cell morphology is similar to traditional small cell carcinoma elsewhere with small uniform round to oval nuclei and evenly distributed finely granular (“salt and pepper”) chromatin. Cytoplasm is scant. Cells are crowded with nuclear moulding and indistinct cell membranes. In contrast, large cell NECs (LCNECs) have a larger cell size than small cell carcinoma and a vesicular nucleus with prominent nucleolus. They can have appreciable eosinophilic cytoplasm. Distinguishing LCNECs from small cell carcinoma can sometimes be a difficult task. Ki-67 index can potentially be helpful as the index of LCNECs ranges from 40 %-80 %while small cell carcinoma averages 80 %[31 ]. In MiNENs the NEC component is more commonly a LCNECs than a small cell carcinoma[32 ,33 ].

    The non-NE component of MiNENs is adenocarcinoma 92 % of the time[2 ]. Squamous cell carcinoma,hepatocellular carcinoma, and mixed adenosquamous carcinoma make up the majority of remaining non-NE components in reported cases thus far[2 ].

    Extent of NE differentiation

    The exact threshold of NED required to define a tumor as a MiNENvsan NNE-NED is an area of current controversy in the literature. As mentioned, the 30 % threshold which persists today was originally chosen arbitrarily. A commonly cited and relatively recent study by Parket al[9 ] provides evidence arguing in favor of lowering the threshold to 10 %[9 ]. The authors examined 88 gastric carcinomas with varying degrees of NED and compared overall survival to 650 gastric carcinomas with no NED. NED of just under 10 % was associated with worse survival: Overall 5 -year survival in cases with < 10 % NED was 85 .6 % compared to only 53 .3 % survival in cases with ≥ 10 % NED.

    Another similar study found 20 % NED to be associated with significantly worse prognosis in adenocarcinomas, again suggesting the 30 % threshold may be too high[34 ]. The current formal threshold for diagnosing a MiNEN remains 30 % but this is likely to be lowered in the future. In the interim while this does preclude a diagnosis of MiNEN in cases with 10 %-30 % NED, we recommend always quantifying the percentage of NED in non-NE tumors and informing the oncologist of the possible prognostic impact, for example by making a diagnostic comment citing the studies above.Regardless of how the report is handled, the possible prognostic impact of 10 %–30 % is an important topic to be raised in multidisciplinary meetings discussing diagnosis and management of these rare tumors.

    The significance of divergent differentiation in NECs is a less well explored topic. This may be because even small degrees of NED, beginning at as little as 10 % as mentioned above, quickly approach the same dismal prognosis as NECs regardless of the size of the non-NE component (Table 1 ).

    Grading

    There is currently no widely accepted system for grading MiNENs. This is somewhat unfortunate because MiNEN is an umbrella term for a wide range of neoplasms whose behaviour can range from indolent (i.e., a MiNEN in which a NET is the most biologically aggressive component) to aggressively malignant, paralleling the prognosis of NECs. Simply designating a tumor as a MiNEN is insufficient and does not convey much useful information. Therefore, it is incumbent upon the pathologist to clearly communicate the nature and aggressiveness of each component present in the tumor to ensure appropriate management.

    Once upon a time...One summer s day a little tailor sat on his table by the window in the best of spirits, and sewed for dear life. As he was sitting thus a peasant woman came down the street, calling out: Good jam to sell, good jam to sell. This sounded sweetly in the tailor s ears; he put his frail1 little head out of the window, and shouted: up here, my good woman, and you ll find a willing customer. The woman climbed up the three flights of stairs with her heavy basket to the tailor s room, and he made her spread out all the pots in a row before him.

    The original publication by La Rosaet al[1 ] in which the term MiNEN was coined also proposed a grading scheme in which MiNENs were divided into low-grade, intermediate grade, and high grade categories[1 ]. Tumors with a NEC component, which constitute the vast majority of MiNENs, would be designated high grade neoplasms. Tumors in which the non-NE component was the most aggressive,such as adenocarcinomas with a NET component, would be intermediate grade. Indolent tumors in which a NET was the most aggressive component would be low-grade. This scheme succinctly classifies MiNENs according to their most aggressive component. It is also clinically useful because the most aggressive component usually drives prognosis and management. While the scheme may not be widely used, it still serves as a useful guide as to how to portray grade in MiNENs.

    Staging

    The fact that MiNENs are considered single clonal neoplasms greatly simplifies staging. The two components do not need to be staged separately as they would in a collision tumor. Standard TNM staging applies asperAJCC guidelines, using the same protocols as for other carcinomas from the same body site. For the rare MiNENs in which a NET is the most aggressive component the protocol for NETs from the same body site is used. There does not appear to be literature yet to consider alternative methods for staging MiNENs.

    Lymph nodes

    While lymph node staging proceeds asperstaging of the rest of the MiNEN as described above, the composition of lymph node metastases in MiNENs is an interesting issue because of the many different possible scenarios: Only one component may have metastasized, or both may have; the components may metastasize together to the same lymph node, or separately to different lymph nodes. Further it is interesting to consider whether the metastatic component of a MiNEN is a better marker of the biologic behavior of the tumor than the de facto assumption that behaviour is dictated by the worst component found in the primary tumor.

    The pattern of metastasis in MiNENs was investigated in a study of 80 patients[35 ]. In approximately 70 % of patients only one component metastasized; this was usually the more aggressive NEC component. In 20 % of patients both components metastasized, but none were found together in the same lymph node. In 10 % of patients there was lymph node metastasis present containing both components within the same node.

    In terms of the components present in metastases, they reflected the composition of the primary tumor; in a tumor composed of 60 % NEC and 40 % adenocarcinoma, roughly 60 % of metastases would be NEC and 40 % would be adenocarcinoma[35 ].

    Included in the study were 3 cases of NNE-NEDs. In all 3 of these cases the metastases were composed solely of the NEC component. Notably, by current criteria these tumors would not have qualified as MiNENs, providing further evidence that < 30 % NED can be biologically significant.

    The question of whether the biologic behaviour of MiNENs is better reflected by the metastatic component or the most aggressive component in the primary tumor is moot since these data show the composition of the metastases simply reflect the composition of the primary tumor; in other words, it is unlikely further useful information will be gained by determining the pattern of lymph node metastasis once the composition of the primary tumor is known. The grading scheme proposed by La Rosa appears to be the most useful gauge of the potential biological behavior of the tumor.

    Reporting

    'MiNEN' is not a diagnosis but rather an umbrella term for mixed NE neoplasms[1 ]. The term in and of itself does not convey useful information to the oncologist. The useful information is knowing the components which make up the tumor, and pathologists must ensure these are communicated clearly toallow oncologists to stratify risk and plan management accordingly.

    Table 1 Prognostic impact of neuroendocrine differentiation (summarized from Park et al[9 ])

    Figure 5 shows the example of the pathology report of a MiNEN. The first line of the report should identify that the tumor is a MiNEN. Because there is currently no widely accepted grading system,grade must be conveyed within the next few lines. The most aggressive or high-grade component should be listed first, and the system by La Rosaet al[1 ] serves a useful guide here[1 ]. A NEC component is the highest possible grade neoplasm found in MiNENs and should always be listed first.Next in the hierarchy of grade usually comes a non-NE carcinoma component, usually an adenocarcinoma, which is then followed by a NET component, and then lastly followed by the lowest grade component possible, a benign epithelial neoplasm such as an adenoma or papilloma. Accordingly, La Rosa's scheme describes tumors driven by a NEC component as high-grade, tumors driven by a carcinoma component intermediate grade, and tumors driven by a NET component low-grade or indolent. For each component listed the histologic subtype and grade should be described the same way they would be as if the component were a pure neoplasm. The percentage of total tumor volume occupied by each component should also be listed.

    We recommend designating non-NE tumors with 10 %-30 % NED (NNE-NEDs) as 'mixed neoplasms'and then reporting them in the same manner as a MiNEN. A diagnostic comment citing the Parket al[9 ]and Jianget al[34 ] studies mentioning the possible prognostic impact of NE components occupying <30 % of the tumor volume may help provide important background information for these rare tumors[9 ,34 ].

    Because of their genetic similarity to adenocarcinomas, we recommend performing the same molecular studies on MiNENs as one would perform for an adenocarcinoma from the same anatomic site. Alterations involving MMR, BRAF V600 E, and Her-2 have been demonstrated to exist in both components of MiNENs, inviting the exciting possibility of using the same targeted therapies during treatment[22 ,25 ,36 ]. Although ideally both components in a MiNEN would be tested individually to allow for better prediction of how the entire tumor will respond to a targeted therapy, in practice this may be very difficult or impossible to achieve with the closely intermingled components.

    PROGNOSIS AND MANAGEMENT

    The rarity of MiNENs, combined with their changing terminology over the years, has made it difficult to examine outcomes data. Controversy exists as to whether MiNENs behave better than pure NECs,but ultimately the prognosis appears to be similar[2 ,30 ,37 ,38 ]. A recently reported survival comparison of 503 NECs, 401 MiNENs, and 2785 adenocarcinomas of the stomach showed that the 5 -year diseasefree survival (DFS) was 47 .5 %, 51 .1 %, and 57 .8 % respectively[37 ]. The shorter DFS of NECs and MiNENs compared to adenocarcinoma was statistically significant while the difference between NECs and MiNENs was not.

    In the digestive system in general, 82 % of MiNENs present with localized disease and 18 % present with distant metastases[2 ]. Patients with localized disease generally proceed to surgical resection. Select patients with advanced disease may undergo palliative resection[38 ]. The median overall survival for localized MiNENs, including regional lymph node metastases (Stages I-III), is 39 mo. For advanced disease with distant metastasis (Stage IV) median overall survival is 11 mo[38 ].

    MiNENs may be missed in patients with an accessible metastasis that is used for the initial diagnostic biopsy. These cases may be diagnosed as pure NECs or pure adenocarcinomas, if resection is not indicated and further tissue is not sampled, thus may result in under recognition of MiNENs[30 ]. This leads to bias in outcome data as lower stage tumors are more likely to undergo surgical resection and be diagnosed as MiNENs whereas higher stage tumors are more likely to be missed and labeled pure NECs or pure adenocarcinomas. Thus, MiNENs may appear to have improved prognosis, when in reality they are just more likely to be diagnosed at a lower stage.

    Figure 5 Sample pathology report. MiNEN: Mixed neuroendocrine-non-neuroendocrine neoplasm.

    Management for these rare tumors is usually discussed at multidisciplinary rounds with the expertise of pathologists and oncologists who have special interest in NE neoplasms. Treatment is tailored towards the most aggressive component of the tumor, which is usually a NEC. MiNENs in which the most aggressive component is an adenocarcinoma (i.e., tumors composed of adenocarcinomas with a NET component) are much rarer, but in these cases treatment is tailored towards the adenocarcinoma component.

    No guidelines exist currently for adjuvant or neoadjuvant chemotherapy. NEC driven tumors are usually treated with etoposide and cisplatin-based regimens[2 ,27 ,39 ]. Adenocarcinoma driven cancers are commonly treated with 5 -FU based backbones, however treatment options vary based on the site of the primary, with chemotherapies for MiNENs arising from a particular organ mirroring the systemic therapy for adenocarcinomas at that site. The oncologist may attempt a tailored combination of therapy in which the agents employed display efficacy against both components[30 ]. Radiation therapy has been suggested in tumors from the esophagus, stomach, rectum, and anus[40 ].

    The genetic similarity of MiNENs to adenocarcinomas and reports ofKRAS, BRAF V600E, APC,MMR, andHER-2amplifications occurring in both components of MiNENs invites the possibility of targeted therapies in these tumors[2 ,22 ,40 ,41 ]. One series of 44 cases found MMR deficiency in 39 % of these tumors[40 ]. While this did not appear to have prognostic impact, it is an exciting finding raising the possibility for potential response to programmed death 1 blockade.

    CONCLUSION

    Mixed NE neoplasms have a complex history particularly in regard to nomenclature which has evolved alongside our increasing recognition of these tumors. The term 'MiNEN' was created to encompass a broader range of non-NE epithelial components beyond just adenocarcinomas. The term also incorporates updates in terminology used for NE neoplasms. MiNEN can be used to refer to tumors outside of the digestive system as well, although the digestive system has been the leading-edge area for these tumors. Diagnosis is in fact very familiar to both pathologists and oncologists alike, with no significant differences compared to diagnosis of each individual neoplasms. Staging is simplified because MiNENs are considered single clonal neoplasms. Prognosis and management are based on, and in general equivalent to, that of the most aggressive component.

    FOOTNOTES

    Author contributions:Toor D performed the majority of the writing; Wang G provided input in writing the paper and contributed histology images; Loree JM provided input and opinions on the clinical management portion of the writing; Gao ZH defined the concepts and ensured the overall quality of the writing; Zhou C designed the outline and coordinated the writing of the paper.

    Conflict-of-interest statement:JL has received consulting fees from Taiho, Ipsen, Novartis, Amgen, Eisai, and Bayer;research funding from Ipsen Biopharmaceuticals, Amgen, and Foundation Medicine.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4 .0 ) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4 .0 /

    Country/Territory of origin:Canada

    ORCID number:Deepak Toor 0000 -0002 -1859 -1246 ; Jonathan M Loree 0000 -0001 -8189 -2132 ; Zu-Hua Gao 0000 -0001 -7232 -0933 ; Gang Wang 0000 -0002 -0225 -4173 ; Chen Zhou 0000 -0002 -7898 -4201 .

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    色网站视频免费| 精品99又大又爽又粗少妇毛片| 午夜福利视频精品| av又黄又爽大尺度在线免费看| 一级,二级,三级黄色视频| 国产探花极品一区二区| 久久毛片免费看一区二区三区| 免费少妇av软件| 久久人人97超碰香蕉20202| 99热全是精品| 国产片特级美女逼逼视频| 久久 成人 亚洲| 亚洲欧洲精品一区二区精品久久久 | 少妇人妻 视频| 母亲3免费完整高清在线观看 | 亚洲人成电影观看| 色网站视频免费| 亚洲国产看品久久| 中文字幕制服av| 久久精品夜色国产| 最近中文字幕高清免费大全6| 多毛熟女@视频| 亚洲av男天堂| 亚洲天堂av无毛| 男女啪啪激烈高潮av片| 国产极品粉嫩免费观看在线| 观看av在线不卡| 男的添女的下面高潮视频| 国产高清不卡午夜福利| 91精品三级在线观看| 国产不卡av网站在线观看| 亚洲欧美成人精品一区二区| 亚洲国产精品成人久久小说| 国产综合精华液| 国产成人精品婷婷| 久久久久久伊人网av| 久久久久精品久久久久真实原创| 麻豆av在线久日| 亚洲一码二码三码区别大吗| 国产白丝娇喘喷水9色精品| 老汉色av国产亚洲站长工具| 国产伦理片在线播放av一区| 在线观看一区二区三区激情| 欧美成人精品欧美一级黄| 日韩中文字幕欧美一区二区 | 国产成人午夜福利电影在线观看| 天天影视国产精品| 少妇精品久久久久久久| 免费黄网站久久成人精品| 丝瓜视频免费看黄片| 如何舔出高潮| 在线观看www视频免费| 最近2019中文字幕mv第一页| 不卡av一区二区三区| 9191精品国产免费久久| 9191精品国产免费久久| 亚洲精品久久午夜乱码| 97在线视频观看| 国产精品三级大全| 高清av免费在线| 色哟哟·www| 亚洲欧洲日产国产| 国产成人91sexporn| 人人妻人人澡人人看| 日产精品乱码卡一卡2卡三| 国产免费福利视频在线观看| 精品国产露脸久久av麻豆| 国产精品一区二区在线观看99| 欧美激情极品国产一区二区三区| 亚洲成av片中文字幕在线观看 | 最近中文字幕2019免费版| 亚洲在久久综合| 亚洲在久久综合| 看免费成人av毛片| 亚洲人成网站在线观看播放| 国产又色又爽无遮挡免| av视频免费观看在线观看| 成年女人在线观看亚洲视频| 精品一区二区三卡| 丁香六月天网| 精品亚洲成a人片在线观看| 亚洲国产精品国产精品| www.自偷自拍.com| 国产深夜福利视频在线观看| 午夜精品国产一区二区电影| 在线免费观看不下载黄p国产| 春色校园在线视频观看| 丰满少妇做爰视频| 亚洲欧美清纯卡通| 久久久久网色| 男人爽女人下面视频在线观看| 久久久久网色| 亚洲欧美清纯卡通| 又黄又粗又硬又大视频| 亚洲国产欧美网| 欧美国产精品va在线观看不卡| 中文乱码字字幕精品一区二区三区| 欧美精品亚洲一区二区| 妹子高潮喷水视频| 国产精品蜜桃在线观看| 97在线人人人人妻| 欧美av亚洲av综合av国产av | 晚上一个人看的免费电影| 欧美成人午夜精品| 久久人人爽人人片av| 亚洲国产色片| 国产精品免费视频内射| 9热在线视频观看99| 国产精品免费视频内射| 97人妻天天添夜夜摸| 女性被躁到高潮视频| 老司机亚洲免费影院| 毛片一级片免费看久久久久| 男男h啪啪无遮挡| 9色porny在线观看| 国产高清国产精品国产三级| 激情五月婷婷亚洲| 久久精品久久精品一区二区三区| 日本爱情动作片www.在线观看| 免费观看性生交大片5| 侵犯人妻中文字幕一二三四区| 黑人巨大精品欧美一区二区蜜桃| 国产欧美日韩一区二区三区在线| 97精品久久久久久久久久精品| 亚洲精品第二区| 一二三四在线观看免费中文在| 成年女人毛片免费观看观看9 | 97精品久久久久久久久久精品| 人妻人人澡人人爽人人| 亚洲婷婷狠狠爱综合网| 精品久久久精品久久久| 亚洲精品国产av成人精品| 亚洲综合精品二区| 午夜福利影视在线免费观看| 激情视频va一区二区三区| 国产乱来视频区| 欧美国产精品va在线观看不卡| 少妇人妻精品综合一区二区| 丰满饥渴人妻一区二区三| 欧美日韩亚洲高清精品| 亚洲美女搞黄在线观看| 天天影视国产精品| 日韩一区二区视频免费看| 男女无遮挡免费网站观看| 菩萨蛮人人尽说江南好唐韦庄| 中文欧美无线码| av免费在线看不卡| 国产精品欧美亚洲77777| 日本av手机在线免费观看| 人人澡人人妻人| 91在线精品国自产拍蜜月| 综合色丁香网| 99九九在线精品视频| 人妻少妇偷人精品九色| 久久久精品区二区三区| 欧美成人精品欧美一级黄| 日韩视频在线欧美| 国产成人一区二区在线| 成人亚洲欧美一区二区av| 亚洲人成77777在线视频| 永久网站在线| 一区在线观看完整版| 各种免费的搞黄视频| 搡老乐熟女国产| 婷婷色综合www| 国产黄色视频一区二区在线观看| 免费黄色在线免费观看| 天天躁夜夜躁狠狠躁躁| 精品国产一区二区三区四区第35| 国产午夜精品一二区理论片| av有码第一页| 成人毛片60女人毛片免费| 日韩av不卡免费在线播放| 亚洲av成人精品一二三区| xxx大片免费视频| 亚洲欧洲精品一区二区精品久久久 | 亚洲美女搞黄在线观看| 久久精品熟女亚洲av麻豆精品| 人人妻人人爽人人添夜夜欢视频| 人人妻人人澡人人爽人人夜夜| 黄频高清免费视频| 欧美亚洲 丝袜 人妻 在线| av福利片在线| 熟女少妇亚洲综合色aaa.| 综合色丁香网| 超碰成人久久| 在线观看www视频免费| 高清在线视频一区二区三区| 另类亚洲欧美激情| www.av在线官网国产| 电影成人av| 中文字幕人妻熟女乱码| 一级片'在线观看视频| 美女xxoo啪啪120秒动态图| 久久 成人 亚洲| 美女国产高潮福利片在线看| 欧美 日韩 精品 国产| 日本欧美视频一区| 成年人免费黄色播放视频| 日韩av在线免费看完整版不卡| 亚洲av成人精品一二三区| 欧美中文综合在线视频| 在线观看免费高清a一片| 欧美国产精品va在线观看不卡| 丝袜在线中文字幕| 久久婷婷青草| 91精品三级在线观看| 久久精品国产亚洲av涩爱| 免费高清在线观看日韩| 这个男人来自地球电影免费观看 | 国产成人精品久久二区二区91 | 国产探花极品一区二区| 天堂中文最新版在线下载| 国产福利在线免费观看视频| 国产精品一区二区在线观看99| 人妻 亚洲 视频| 久久久国产精品麻豆| 交换朋友夫妻互换小说| 99久久中文字幕三级久久日本| 两性夫妻黄色片| 黑人猛操日本美女一级片| 美国免费a级毛片| 久久精品久久久久久久性| 日韩电影二区| 妹子高潮喷水视频| 巨乳人妻的诱惑在线观看| 在线精品无人区一区二区三| 国产福利在线免费观看视频| 久久精品国产自在天天线| 男女边吃奶边做爰视频| 人妻人人澡人人爽人人| 三上悠亚av全集在线观看| 国产精品香港三级国产av潘金莲 | 亚洲av福利一区| 青青草视频在线视频观看| 国产片特级美女逼逼视频| 精品亚洲成国产av| 精品人妻熟女毛片av久久网站| 日韩一本色道免费dvd| 十分钟在线观看高清视频www| 国产精品一区二区在线不卡| 热99国产精品久久久久久7| 亚洲图色成人| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 久久精品国产亚洲av高清一级| 99香蕉大伊视频| 黄片播放在线免费| 国产精品免费视频内射| 男人添女人高潮全过程视频| 欧美日韩综合久久久久久| 观看av在线不卡| 两个人看的免费小视频| 99久国产av精品国产电影| 亚洲国产精品国产精品| 国产日韩欧美亚洲二区| 精品少妇黑人巨大在线播放| 视频在线观看一区二区三区| 国产一区亚洲一区在线观看| 免费观看性生交大片5| 丝袜脚勾引网站| 国产精品麻豆人妻色哟哟久久| 考比视频在线观看| 高清在线视频一区二区三区| 搡老乐熟女国产| 91aial.com中文字幕在线观看| 亚洲伊人久久精品综合| 香蕉国产在线看| 欧美日韩亚洲国产一区二区在线观看 | 欧美xxⅹ黑人| 色吧在线观看| 午夜老司机福利剧场| 18禁观看日本| 高清视频免费观看一区二区| 一级片免费观看大全| 大码成人一级视频| 2021少妇久久久久久久久久久| 高清在线视频一区二区三区| 国产高清不卡午夜福利| 日韩精品有码人妻一区| 免费观看无遮挡的男女| 中文字幕亚洲精品专区| 久久久久国产网址| 一区二区三区精品91| 亚洲精品国产色婷婷电影| 97精品久久久久久久久久精品| 巨乳人妻的诱惑在线观看| 日本免费在线观看一区| 少妇人妻 视频| 精品卡一卡二卡四卡免费| 久久精品国产亚洲av天美| 国产一区二区三区综合在线观看| 汤姆久久久久久久影院中文字幕| 亚洲欧洲日产国产| 亚洲一区中文字幕在线| 日韩视频在线欧美| 在线看a的网站| 大码成人一级视频| 亚洲av免费高清在线观看| 日本欧美视频一区| 日本-黄色视频高清免费观看| 精品一区二区免费观看| 嫩草影院入口| 男人舔女人的私密视频| 黄色一级大片看看| 日韩精品有码人妻一区| 一二三四中文在线观看免费高清| 亚洲精品中文字幕在线视频| 日韩在线高清观看一区二区三区| 亚洲精品自拍成人| 青青草视频在线视频观看| 人妻系列 视频| 国产精品国产av在线观看| 欧美精品人与动牲交sv欧美| 亚洲国产欧美在线一区| 日本欧美国产在线视频| 日本91视频免费播放| 亚洲成人av在线免费| 日韩制服骚丝袜av| 亚洲成人手机| 精品亚洲乱码少妇综合久久| 欧美最新免费一区二区三区| 精品国产一区二区久久| av国产久精品久网站免费入址| 亚洲图色成人| 国产av码专区亚洲av| 菩萨蛮人人尽说江南好唐韦庄| 中文乱码字字幕精品一区二区三区| 少妇的逼水好多| 成人手机av| 国产日韩一区二区三区精品不卡| 亚洲欧美日韩另类电影网站| 高清视频免费观看一区二区| 超色免费av| 亚洲欧洲精品一区二区精品久久久 | 国产精品国产av在线观看| 美女大奶头黄色视频| 91久久精品国产一区二区三区| 国产亚洲一区二区精品| 欧美人与善性xxx| 欧美日韩视频精品一区| 久久青草综合色| 丝瓜视频免费看黄片| 99精国产麻豆久久婷婷| 各种免费的搞黄视频| 热99国产精品久久久久久7| 波多野结衣av一区二区av| 成人毛片60女人毛片免费| 欧美少妇被猛烈插入视频| 亚洲欧美日韩另类电影网站| 99re6热这里在线精品视频| 日本午夜av视频| 午夜91福利影院| 久久久国产欧美日韩av| 纵有疾风起免费观看全集完整版| 18禁裸乳无遮挡动漫免费视频| 午夜老司机福利剧场| 国产精品香港三级国产av潘金莲 | 欧美日韩精品网址| 欧美变态另类bdsm刘玥| 亚洲精品,欧美精品| 日本爱情动作片www.在线观看| 丝瓜视频免费看黄片| 狠狠婷婷综合久久久久久88av| 久久久久视频综合| 久久久久网色| 人妻 亚洲 视频| 免费人妻精品一区二区三区视频| 搡老乐熟女国产| 中文字幕制服av| 欧美xxⅹ黑人| 中国国产av一级| 中文字幕亚洲精品专区| 国产有黄有色有爽视频| 日韩av免费高清视频| 亚洲三区欧美一区| 国产一区二区三区综合在线观看| 日本vs欧美在线观看视频| 夜夜骑夜夜射夜夜干| 男女无遮挡免费网站观看| 欧美亚洲 丝袜 人妻 在线| 久久99热这里只频精品6学生| 丝瓜视频免费看黄片| 色网站视频免费| 日韩av免费高清视频| 国产精品一二三区在线看| 日本黄色日本黄色录像| 亚洲av男天堂| a 毛片基地| 深夜精品福利| 久久久精品国产亚洲av高清涩受| av不卡在线播放| 少妇被粗大的猛进出69影院| 午夜av观看不卡| 亚洲婷婷狠狠爱综合网| 人妻 亚洲 视频| 美女主播在线视频| 丰满少妇做爰视频| 人妻 亚洲 视频| 哪个播放器可以免费观看大片| av电影中文网址| 青春草视频在线免费观看| 免费人妻精品一区二区三区视频| 国产成人免费无遮挡视频| 精品亚洲乱码少妇综合久久| 18在线观看网站| 免费观看无遮挡的男女| 91成人精品电影| 丝袜人妻中文字幕| 男男h啪啪无遮挡| 精品国产一区二区三区四区第35| 大香蕉久久成人网| 大片免费播放器 马上看| 美女午夜性视频免费| 日韩av在线免费看完整版不卡| 嫩草影院入口| 精品一区二区三卡| 国产极品天堂在线| 久久 成人 亚洲| 少妇精品久久久久久久| 男的添女的下面高潮视频| 日本av手机在线免费观看| 日日啪夜夜爽| 成人毛片a级毛片在线播放| 国产成人av激情在线播放| 国产日韩欧美亚洲二区| 一级,二级,三级黄色视频| 免费观看性生交大片5| 国产在线一区二区三区精| 男女啪啪激烈高潮av片| 午夜福利视频精品| 精品视频人人做人人爽| 午夜av观看不卡| 国语对白做爰xxxⅹ性视频网站| 国产精品国产av在线观看| 日韩不卡一区二区三区视频在线| av女优亚洲男人天堂| 岛国毛片在线播放| 自拍欧美九色日韩亚洲蝌蚪91| 免费看av在线观看网站| 精品国产露脸久久av麻豆| 亚洲国产精品一区三区| 精品亚洲成国产av| 91国产中文字幕| 丝袜美足系列| 巨乳人妻的诱惑在线观看| 国产 一区精品| 亚洲欧美清纯卡通| 99re6热这里在线精品视频| 日韩一卡2卡3卡4卡2021年| 黄色视频在线播放观看不卡| 精品人妻熟女毛片av久久网站| 亚洲国产欧美在线一区| 99re6热这里在线精品视频| 成人国产麻豆网| 天堂俺去俺来也www色官网| 人成视频在线观看免费观看| 啦啦啦中文免费视频观看日本| 天天影视国产精品| 欧美精品一区二区免费开放| 最近手机中文字幕大全| 伦精品一区二区三区| 国产激情久久老熟女| 熟妇人妻不卡中文字幕| 亚洲精品国产色婷婷电影| 国产爽快片一区二区三区| 91午夜精品亚洲一区二区三区| 亚洲综合精品二区| 久久鲁丝午夜福利片| 色哟哟·www| 亚洲伊人色综图| 久久99精品国语久久久| 超碰成人久久| 国产在线视频一区二区| av片东京热男人的天堂| 国产无遮挡羞羞视频在线观看| 国产成人精品久久久久久| 免费观看性生交大片5| 成年女人在线观看亚洲视频| 久久久精品国产亚洲av高清涩受| 黄网站色视频无遮挡免费观看| 制服丝袜香蕉在线| 卡戴珊不雅视频在线播放| 精品人妻在线不人妻| 亚洲av男天堂| 老汉色∧v一级毛片| a级毛片在线看网站| 午夜91福利影院| 在线天堂中文资源库| 国产精品 欧美亚洲| 午夜精品国产一区二区电影| 2022亚洲国产成人精品| 一区二区三区乱码不卡18| 十八禁网站网址无遮挡| 国产精品人妻久久久影院| 日韩制服丝袜自拍偷拍| 中文欧美无线码| 午夜激情av网站| 国产精品av久久久久免费| 91在线精品国自产拍蜜月| 国产成人午夜福利电影在线观看| 七月丁香在线播放| 999精品在线视频| 日产精品乱码卡一卡2卡三| 不卡av一区二区三区| 伦理电影大哥的女人| 久久人人爽av亚洲精品天堂| 一个人免费看片子| 日本色播在线视频| 亚洲欧美一区二区三区国产| 欧美xxⅹ黑人| 免费观看无遮挡的男女| 人人妻人人爽人人添夜夜欢视频| 多毛熟女@视频| 在线观看一区二区三区激情| 精品国产一区二区久久| 中文字幕亚洲精品专区| 这个男人来自地球电影免费观看 | 久久久久久久精品精品| 少妇的逼水好多| 国产成人精品婷婷| 高清在线视频一区二区三区| 69精品国产乱码久久久| 日韩中文字幕欧美一区二区 | 秋霞在线观看毛片| 亚洲av日韩在线播放| 又黄又粗又硬又大视频| 亚洲精华国产精华液的使用体验| 亚洲精品乱久久久久久| 老熟女久久久| av免费观看日本| 性色av一级| 2022亚洲国产成人精品| 欧美精品亚洲一区二区| 制服丝袜香蕉在线| av国产久精品久网站免费入址| 波野结衣二区三区在线| 国产成人免费无遮挡视频| 伦精品一区二区三区| 人人澡人人妻人| 蜜桃在线观看..| 免费av中文字幕在线| 巨乳人妻的诱惑在线观看| 可以免费在线观看a视频的电影网站 | 男女国产视频网站| 成年女人在线观看亚洲视频| 自拍欧美九色日韩亚洲蝌蚪91| 午夜福利视频在线观看免费| 国产成人免费观看mmmm| 99久久人妻综合| 久久久精品国产亚洲av高清涩受| 女人被躁到高潮嗷嗷叫费观| 男人操女人黄网站| 999精品在线视频| 一区在线观看完整版| 亚洲精品在线美女| 青草久久国产| 超碰97精品在线观看| 欧美人与性动交α欧美精品济南到 | 欧美人与性动交α欧美软件| 国产男女超爽视频在线观看| 亚洲成人手机| 色网站视频免费| 亚洲欧美清纯卡通| 熟女电影av网| 性色avwww在线观看| 久久久久久久久久人人人人人人| 免费观看性生交大片5| 捣出白浆h1v1| 国产av国产精品国产| 五月开心婷婷网| 卡戴珊不雅视频在线播放| videosex国产| 久久国产亚洲av麻豆专区| av有码第一页| av国产久精品久网站免费入址| 久久久久久久久久人人人人人人| 99久久综合免费| 欧美最新免费一区二区三区| 99九九在线精品视频| 日本免费在线观看一区| 2021少妇久久久久久久久久久| av.在线天堂| 免费日韩欧美在线观看| 成年美女黄网站色视频大全免费| 超碰成人久久| 午夜福利网站1000一区二区三区| av电影中文网址| 免费观看av网站的网址| 色婷婷久久久亚洲欧美| 中文天堂在线官网| 国产乱来视频区| 国产熟女午夜一区二区三区| 老汉色∧v一级毛片| 五月伊人婷婷丁香| 久久久久久久国产电影| 少妇人妻 视频| 日本91视频免费播放| 有码 亚洲区| 亚洲精品一二三| 黄片播放在线免费| 成年人免费黄色播放视频| av卡一久久| 免费观看av网站的网址| 丝袜脚勾引网站| av在线观看视频网站免费| 香蕉精品网在线| 精品一区二区三区四区五区乱码 | 亚洲精品aⅴ在线观看| 97精品久久久久久久久久精品| 欧美精品一区二区免费开放| 精品99又大又爽又粗少妇毛片| 成人国产av品久久久| 十分钟在线观看高清视频www| 亚洲三级黄色毛片| 亚洲国产精品一区三区|